Follicular lymphoma grade IIIb, lymph nodes of head, face, and neck
ICD-10 C82.41 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiib, lymph nodes of head, face, and neck.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIb indicates a more aggressive form of the disease, where more than 50% of the neoplastic cells are large cells, often leading to a more rapid progression. This specific code pertains to cases where the lymphoma is localized to the lymph nodes of the head, face, and neck. Patients may present with painless lymphadenopathy in these regions, and the disease can be associated with B-symptoms such as fever, night sweats, and weight loss. Diagnosis typically involves imaging studies, biopsy, and histological examination to confirm the presence of follicular lymphoma and assess the grade. Treatment options may include watchful waiting, chemotherapy, immunotherapy, or radiation therapy, depending on the stage and symptoms of the disease. The prognosis varies based on the individual’s overall health, the extent of the disease, and response to treatment.
Detailed pathology reports, imaging studies, and treatment plans must be documented.
Patients presenting with lymphadenopathy, B-symptoms, or those undergoing treatment for follicular lymphoma.
Accurate grading and staging are crucial for treatment planning and coding.
Imaging reports must clearly indicate the presence and location of lymphadenopathy.
Imaging studies performed to assess lymph node involvement in suspected lymphoma cases.
Radiologists should ensure that findings correlate with clinical documentation for accurate coding.
Used to assess overall health and detect blood disorders in patients with lymphoma.
Document the reason for the CBC and any relevant findings.
Hematologists should correlate CBC results with clinical findings.
The grade indicates the aggressiveness of the lymphoma, with higher grades (like IIIb) suggesting a more aggressive disease that may require more intensive treatment.
